Insights Header image
Insights Header image
Insights Header image

Government of Alberta to Regulate Health Care Practitioners Administering Psychedelics

November 9, 2022 Capital Markets Bulletin 2 minute read

On October 5, 2022, Alberta announced amendments (the “Amendments”) to the Mental Health Services Protection Regulation[1], which are expected to come into effect on January 16, 2023. The Amendments seek to implement a new framework in regulating and licensing health care providers in connection with administering psychedelics as part of treatment for mental health conditions. Over the last few years, psychedelics, including psilocybin, have experienced a renaissance in potential treatment of conditions such as treatment-resistant depression and end-of-life distress.  The psychedelic compounds specifically incorporated in the Amendments include psilocybin, psilocin, MDMA, LSD, mescaline (peyote), DMT, 5 methoxy DMT and ketamine.[2]

Broadly, the Amendments will implement new requirements for psychiatrists, or physicians who are working in consultation with a psychiatrist, prescribing and administering psychedelics, other than for ketamine administered outside of the context of psychedelic assisted therapy. The new licensing framework will only apply to therapy used to treat mental health conditions, and does not extend to potential uses of psychedelics to treat physical disorders, including pain management.

As a reminder, psychedelics are regulated at the federal level under the Controlled Drugs and Substances Act (the “CDSA”). Activities related to controlled substances under the CDSA require licensing by Health Canada; however, patients may obtain access by way of an exemption under Health Canada’s special access programs or pursuant to Section 56 of the CDSA. It is worthy of note that the federal regime remains unchanged and still controls individuals’ access to psychedelics.

The development with respect to the Amendments can be viewed as a recognition that psychedelic assisted therapy has a place in health care offerings, and accordingly, the Government of Alberta has taken the steps to indicate a standard that medical practitioners must meet to provide the relevant care. The limited scope of the Amendments and the focus on mental health conditions and the role of psychiatrists could impact access by patients in a field which is still relatively nascent in Canada. As such, close attention should be paid to the effects of the implementation of the Amendments and whether there are any impacts on the regulatory framework on a federal level. Specifically, it will be important to see whether or not the federal regime evolves on accessibility to psychedelics by individuals with mental health or physical conditions.

McMillan will continue to monitor developments to the industry and regulations as they arise.

[1] Alberta Regulation 114/2021 [AB Reg].
[2] Part 3, AB Reg.

by Sasa Jarvis, Leila Rafi, Julia Loney, Anthony Labib, Kiira Kaarid (Articling Student)

A Cautionary Note

The foregoing provides only an overview and does not constitute legal advice. Readers are cautioned against making any decisions based on this material alone. Rather, specific legal advice should be obtained.

© McMillan LLP 2022

Insights (5 Posts)View More

Featured Insight

Automotive Webinar Series | Part III: Where Rubber Meets the Road: Automotive Litigation Update

At this session, our panel of experts will provide a panoramic view of the evolution of automotive class actions across Canada, a review of best practices for managing disputes with distributors and franchisees, and
insights into litigation and disclosure obligations arising from automotive industry labour issues.

Details
Wednesday, November 29, 2023
Featured Insight

Automotive Webinar Series | Part II: Looking towards the Future: Automotive Legislation Updates

Our panel of professionals will highlight important changes impacting the automotive industry in Canada’s ever-evolving regulatory landscape including updates to cross-border sales legislation, advertising obligations arising from drip pricing provisions under the Competition Act and understanding Transport Canada's lates enforcement tool: administrative monetary penalties.

Details
Tuesday, November 7, 2023
Featured Insight

Nothing Casual about it: Hotel Faces Employees’ Class Action over Employment Benefit Changes

Hotel faces employees' class action over employment benefit changes.

Read More
Sep 29, 2023
Featured Insight

“Mend your speech a little, lest it may mar your fortunes”: Are Employee Defamation Cases A Fool’s Errand?

This bulletin discusses the recent decision in Williams v. Vac Developments Limited regarding gag defamation proceedings commenced by employers.

Read More
Sep 27, 2023
Featured Insight

Overholding in Commercial Leasing

The concept of overholding is often misunderstood and deserves more attention in commercial leases, given the significant consequences for landlords and tenants.

Read More
Sep 27, 2023